Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age

Pediatric Infectious Disease Journal

Volumn 30, Issue 8, 2011, Pages 703-705

  Van Damme, Pierre ^a   Kafeja, Froukje ^a   Van Der Wielen, Marie ^a   Leyssen, Maarten ^b   Jacquet, Jeanne Marie ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

children; combined; HAB; long term; two dose

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VACCINATION REACTION;

EID: 79960630041     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31822855a0     Document Type: Review

References (10)

1. Van Damme P, Leroux-Roels G, Law B, et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol. 2001;65:6-13.
2. Burgess MA, Rodger AJ, Waite SA, et al. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine Twinrix in healthy adolescent volunteers an open randomised study. Vaccine. 2001;19:4835-4841. (Pubitemid 32800770)
3. Kurugol Z, Mutlubas F, Ozacar T. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. Vaccine. 2005;23:2876-2880. (Pubitemid 40386489)
4. Levie K, Beran J, Collard F, et al. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years. Vaccine. 2002;20:2579-2584. (Pubitemid 34615598)
5. Van Damme P, Van Der Wielen M. Combining hepatitis A and B vaccination in children and adolescents. Vaccine. 2001;19:2407-2412. (Pubitemid 32234250)
6. Van Der Wielen M, Van Damme P, Collard F. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years. Pediatr Infect Dis J. 2000;19:848-853.
7. Cambron P, Jacquet JM, Hoet B, et al. Development, technical and clinical validation of a quantitative 2 ELISA for the detection of human antibodies to hepatitis B surface 3 antigen (HBsAg) in recipients of recombinant HBV vaccine. Clin Vaccine Immunol. 2009;16:1236-1246.
8. Marshall H, Nolan T, Domingo JD, et al. Long-term (5 years) antibody persistence following two-and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine. 2010;28:4411-4415.
9. Burgess MA, McIntyre PB, Hellard M, et al. Antibody persistence six years after two doses of combined hepatitis A and B vaccine. Vaccine. 2010;28: 2222-2226.
10. Van Herck K, Leroux-Roels G, Van Damme P, et al. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. Travel Med Infect Dis. 2007;5:171-175. (Pubitemid 46585955)